Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis

References

• Weidner WS, Barbarino P. P4-443: the state of the art of dementia research: new frontiers. Alzheimers Dement. 2019;15(7S_Part_28):1473. doi:10.1016/j.jalz.2019.06.4115
   Google Scholar
• Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell. 2012;148(6):1188–1203. doi:10.1016/j.cell.2012.02.022
   PubMed Web of Science ®Google Scholar
• Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33. doi:10.1038/s41572-021-00269-y
   PubMed Web of Science ®Google Scholar
• Liang CQ, Li YM. Peptides for disrupting and degrading amyloids. Curr Opin Chem Biol. 2021;64:124–130. doi:10.1016/j.cbpa.2021.05.011
   PubMed Web of Science ®Google Scholar
• Mittal S, Prajapati KP, Ansari M, et al. Autooxidation of curcumin in physiological buffer causes an enhanced synergistic anti-amyloid effect. Int J Biol Macromol. 2023;235:123629. doi:10.1016/j.ijbiomac.2023.123629
   PubMed Web of Science ®Google Scholar
• Alam D, Naaz F, Islam A, et al. Role of sugar osmolytes and their nano-counterparts as inhibitors in protein fibrillation. J Mol Liq. 2023;386:122479. doi:10.1016/j.molliq.2023.122479
   Web of Science ®Google Scholar
• Borah P, Mattaparthi VSK. Insights into resveratrol as an inhibitor against Aβ1-42 peptide aggregation: a molecular dynamics simulation study. Curr Chem Biol. 2023;17(1):67–78. doi:10.2174/2212796817666221221151713
   Google Scholar
• Jimenez-Aliaga K, Bermejo-Bescos P, Benedi J, et al. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci. 2011;89(25–26):939–945. doi:10.1016/j.lfs.2011.09.023
   PubMed Web of Science ®Google Scholar
• Fang M, Zhang Q, Guan P, et al. Insights into molecular mechanisms of EGCG and apigenin on disrupting amyloid-beta protofibrils based on molecular dynamics simulations. J Phys Chem B. 2022;126(41):8155–8165. doi:10.1021/acs.jpcb.2c04230
   PubMed Web of Science ®Google Scholar
• Ehrnhoefer DE, Bieschke J, Boeddrich A, et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol. 2008;15(6):558–566. doi:10.1038/nsmb.1437
   PubMed Web of Science ®Google Scholar
• Ahmed R, VanSchouwen B, Jafari N, et al. Molecular mechanism for the (-)-epigallocatechin gallate-induced toxic to nontoxic remodeling of Abeta oligomers. J Am Chem Soc. 2017;139(39):13720–13734. doi:10.1021/jacs.7b05012
   PubMed Web of Science ®Google Scholar
• Hyung SJ, DeToma AS, Brender JR, et al. Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-beta species. Proc Natl Acad Sci U S A. 2013;110(10):3743–3748. doi:10.1073/pnas.1220326110
   PubMed Web of Science ®Google Scholar
• Acharya A, Stockmann J, Beyer L, et al. The effect of (-)-epigallocatechin-3-gallate on the amyloid-beta secondary structure. Biophys J. 2020;119(2):349–359. doi:10.1016/j.bpj.2020.05.033
   PubMed Web of Science ®Google Scholar
• Palhano FL, Lee J, Grimster NP, et al. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J Am Chem Soc. 2013;135(20):7503–7510. doi:10.1021/ja3115696
   PubMed Web of Science ®Google Scholar
• Valverde-Salazar V, Ruiz-Gabarre D, Garcia-Escudero V. Alzheimer’s disease and green tea: epigallocatechin-3-gallate as a modulator of inflammation and oxidative stress. Antioxidants. 2023;12(7):1460. doi:10.3390/antiox12071460
   Web of Science ®Google Scholar
• Liu M, Chen F, Lin T, et al. (-)-Epigallocatechin-3-gallate ameliorates learning and memory impairments by attenuating peroxidation in APP/PS1 transgenic mice. Mol Neurodegener. 2012;7(S1):S29. doi:10.1186/1750-1326-7-s1-s29
   PubMedGoogle Scholar
• Chan S, Kantham S, Rao VM, et al. Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer’s disease. Food Chem. 2016;199:185–194. doi:10.1016/j.foodchem.2015.11.118
   PubMed Web of Science ®Google Scholar
• Seidler PM, Murray KA, Boyer DR, et al. Structure-based discovery of small molecules that disaggregate Alzheimer’s disease tissue derived tau fibrils in vitro. Nat Commun. 2022;13(1):5451. doi:10.1038/s41467-022-32951-4
   PubMed Web of Science ®Google Scholar
• Sahadevan R, Singh S, Binoy A, et al. Chemico-biological aspects of (-)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: current status and future prospects. Crit Rev Food Sci Nutr. 2022:1–30. doi:10.1080/10408398.2022.2068500
   Web of Science ®Google Scholar
• Lambert JD, Lee MJ, Lu H, et al. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr. 2003;133(12):4172–4177. doi:10.1093/jn/133.12.4172
   PubMed Web of Science ®Google Scholar
• Yang QQ, Wei XL, Fang YP, et al. Nanochemoprevention with therapeutic benefits: an updated review focused on epigallocatechin gallate delivery. Crit Rev Food Sci Nutr. 2020;60(8):1243–1264. doi:10.1080/10408398.2019.1565490
   PubMed Web of Science ®Google Scholar
• Aggarwal V, Tuli HS, Tania M, et al. Molecular mechanisms of action of epigallocatechin gallate in cancer: recent trends and advancement. Semin Cancer Biol. 2022;80:256–275. doi:10.1016/j.semcancer.2020.05.011
   PubMed Web of Science ®Google Scholar
• Dai W, Ruan C, Zhang Y, et al. Bioavailability enhancement of EGCG by structural modification and nano-delivery: a review. J Funct Foods. 2020;65:103732. doi:10.1016/j.jff.2019.103732
   Web of Science ®Google Scholar
• Lin X, Liu W, Dong X, et al. Epigallocatechin gallate-derived carbonized polymer dots: a multifunctional scavenger targeting Alzheimer’s beta-amyloid plaques. Acta Biomater. 2023;157:524–537. doi:10.1016/j.actbio.2022.11.063
   PubMed Web of Science ®Google Scholar
• Yan C, Wang C, Shao X, et al. Dual-targeted carbon-dot-drugs nanoassemblies for modulating Alzheimer’s related amyloid-beta aggregation and inhibiting fungal infection. Mater Today Bio. 2021;12:100167. doi:10.1016/j.mtbio.2021.100167
   PubMedGoogle Scholar
• Istenic K, Cerc Korosec R, Poklar Ulrih N. Encapsulation of (-)-epigallocatechin gallate into liposomes and into alginate or chitosan microparticles reinforced with liposomes. J Sci Food Agric. 2016;96(13):4623–4632. doi:10.1002/jsfa.7691
   PubMed Web of Science ®Google Scholar
• Debnath K, Shekhar S, Kumar V, et al. Efficient inhibition of protein aggregation, disintegration of aggregates, and lowering of cytotoxicity by green tea polyphenol-based self-assembled polymer nanoparticles. ACS Appl Mater Interfaces. 2016;8(31):20309–20318. doi:10.1021/acsami.6b06853
   PubMed Web of Science ®Google Scholar
• John T, Adler J, Elsner C, et al. Mechanistic insights into the size-dependent effects of nanoparticles on inhibiting and accelerating amyloid fibril formation. J Colloid Interface Sci. 2022;622:804–818. doi:10.1016/j.jcis.2022.04.134
   PubMed Web of Science ®Google Scholar
• Gao G, Zhang M, Gong D, et al. The size-effect of gold nanoparticles and nanoclusters in the inhibition of amyloid-beta fibrillation. Nanoscale. 2017;9(12):4107–4113. doi:10.1039/c7nr00699c
   PubMed Web of Science ®Google Scholar
• Tapia-Arellano A, Gallardo-Toledo E, Celis F, et al. The curvature of gold nanoparticles influences the exposure of amyloid-beta and modulates its aggregation process. Mater Sci Eng C Mater Biol Appl. 2021;128:112269. doi:10.1016/j.msec.2021.112269
   PubMed Web of Science ®Google Scholar
• Kim Y, Park JH, Lee H, et al. How do the size, charge and shape of nanoparticles affect amyloid beta aggregation on brain lipid bilayer? Sci Rep. 2016;6:19548. doi:10.1038/srep19548
   PubMed Web of Science ®Google Scholar
• Sukhanova A, Poly S, Bozrova S, et al. Nanoparticles with a specific size and surface charge promote disruption of the secondary structure and amyloid-like fibrillation of human insulin under physiological conditions. Front Chem. 2019;7:480. doi:10.3389/fchem.2019.00480
   PubMed Web of Science ®Google Scholar
• Liao YH, Chang YJ, Yoshiike Y, et al. Negatively charged gold nanoparticles inhibit Alzheimer’s amyloid-beta fibrillization, induce fibril dissociation, and mitigate neurotoxicity. Small. 2012;8(23):3631–3639. doi:10.1002/smll.201201068
   PubMed Web of Science ®Google Scholar
• Linse S, Cabaleiro-Lago C, Xue WF, et al. Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A. 2007;104(21):8691–8696. doi:10.1073/pnas.0701250104
   PubMed Web of Science ®Google Scholar
• Cabaleiro-Lago C, Quinlan-Pluck F, Lynch I, et al. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc. 2008;130(46):15437–15443. doi:10.1021/ja8041806
   PubMed Web of Science ®Google Scholar
• Vicente-Zurdo D, Rosales-Conrado N, Leon-Gonzalez ME. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer’s disease: a bioanalytical review. Talanta. 2024;269:125519. doi:10.1016/j.talanta.2023.125519
   PubMed Web of Science ®Google Scholar
• Aili M, Zhou K, Zhan J, et al. Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer’s disease. J Mater Chem B. 2023;11(36):8605–8621. doi:10.1039/d3tb01023f
   PubMed Web of Science ®Google Scholar
• Sela H, Cohen H, Elia P, et al. Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB). J Nanobiotechnology. 2015;13:71. doi:10.1186/s12951-015-0133-1
   PubMed Web of Science ®Google Scholar
• Sanchis-Gual R, Coronado-Puchau M, Mallah T, et al. Hybrid nanostructures based on gold nanoparticles and functional coordination polymers: chemistry, physics and applications in biomedicine, catalysis and magnetism. Coord Chem Rev. 2023;480:215025. doi:10.1016/j.ccr.2023.215025
   Web of Science ®Google Scholar
• Rai A, Seena S, Gagliardi T, et al. Advances in the design of amino acid and peptide synthesized gold nanoparticles for their applications. Adv Colloid Interface Sci. 2023;318:102951. doi:10.1016/j.cis.2023.102951
   PubMed Web of Science ®Google Scholar
• Hou K, Zhao J, Wang H, et al. Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease. Nat Commun. 2020;11(1):4790. doi:10.1038/s41467-020-18525-2
   PubMed Web of Science ®Google Scholar
• Deeths TM, Stanley RJ. Parametrial calcification in cervical carcinoma patients treated with radioactive gold. AJR Am J Roentgenol. 1976;127(3):511–513. doi:10.2214/ajr.127.3.511
   PubMed Web of Science ®Google Scholar
• Khoobchandani M, Katti K, Maxwell A, et al. Laminin receptor-avid nanotherapeutic EGCg-AuNPs as a potential alternative therapeutic approach to prevent restenosis. Int J Mol Sci. 2016;17(3):316. doi:10.3390/ijms17030316
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou X, Yu Q, et al. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-beta aggregation and cytotoxicity. ACS Appl Mater Interfaces. 2014;6(11):8475–8487. doi:10.1021/am501341u
   PubMed Web of Science ®Google Scholar
• Liu H, Yu L, Dong X, et al. Synergistic effects of negatively charged hydrophobic nanoparticles and (-)-epigallocatechin-3-gallate on inhibiting amyloid beta-protein aggregation. J Colloid Interface Sci. 2017;491:305–312. doi:10.1016/j.jcis.2016.12.038
   PubMed Web of Science ®Google Scholar
• Alle M, Lee SH, Kim JC. Ultrafast synthesis of gold nanoparticles on cellulose nanocrystals via microwave irradiation and their dyes-degradation catalytic activity. J Mater Sci Technol. 2020;41:168–177. doi:10.1016/j.jmst.2019.11.003
   Web of Science ®Google Scholar
• Liu F, Liu X, Astruc D, et al. Dendronized triazolyl-containing ferrocenyl polymers as stabilizers of gold nanoparticles for recyclable two-phase reduction of 4-nitrophenol. J Colloid Interface Sci. 2019;533:161–170. doi:10.1016/j.jcis.2018.08.062
   PubMed Web of Science ®Google Scholar
• Vijayan A, Nair LV, Sandhyarani N. Gold cluster incorporated Rhenium disulfide: an efficient catalyst towards electrochemical and photoelectrochemical hydrogen evolution reaction. Electrochim Acta. 2023;446:142073. doi:10.1016/j.electacta.2023.142073
   Web of Science ®Google Scholar
• Atia A, Abdel-Monem YK, Salama AH, et al. Green gold@chitosan nanocomposite via solid-state synthesis; a separable catalyst for reduction of Cr(IV). J Ind Eng Chem. 2023;117:342–351. doi:10.1016/j.jiec.2022.10.022
   Web of Science ®Google Scholar
• Lee KX, Shameli K, Yew YP, et al. Recent developments in the facile bio-synthesis of gold nanoparticles (AuNPs) and their biomedical applications. Int J Nanomed. 2020;15:275–300. doi:10.2147/IJN.S233789
   PubMed Web of Science ®Google Scholar
• Li F, Qasim S, Li D, et al. Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator. Semin Cancer Biol. 2022;83:335–352. doi:10.1016/j.semcancer.2020.11.018
   PubMed Web of Science ®Google Scholar
• Choi I, Wang M, Yoo S, et al. Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Nat Cell Biol. 2023;25(7):963–974. doi:10.1038/s41556-023-01158-0
   PubMed Web of Science ®Google Scholar
• Sun D, Li N, Zhang W, et al. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer’s disease. Colloids Surf B Biointerfaces. 2016;148:116–129. doi:10.1016/j.colsurfb.2016.08.052
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Yoshida J, Dibwe DF, et al. Orengedokuto and san’oshashinto improve memory deficits by inhibiting aging-dependent activation of glycogen synthase kinase-3beta. J Tradit Complement Med. 2019;9(4):328–335. doi:10.1016/j.jtcme.2018.12.001
   PubMedGoogle Scholar
• Zheng J, Xie Y, Ren L, et al. GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer’s disease. Mol Metab. 2021;47:101180. doi:10.1016/j.molmet.2021.101180
   PubMed Web of Science ®Google Scholar
• McLafferty FW. Tandem mass spectrometry. Science. 1981;214(4518):280–287. doi:10.1126/science.7280693
   PubMed Web of Science ®Google Scholar
• Zhang A, Sun H, Yan G, et al. Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis. TRAC Trends in Analytical Chemistry. 2017;94:70–76. doi:10.1016/j.trac.2017.07.007
   Web of Science ®Google Scholar
• Guzzi C, Colombo L, Luigi A, et al. Flavonoids and their glycosides as anti-amyloidogenic compounds: abeta1-42 interaction studies to gain new insights into their potential for Alzheimer’s Disease prevention and therapy. Chem Asian J. 2017;12(1):67–75. doi:10.1002/asia.201601291
   PubMed Web of Science ®Google Scholar
• Ferreira de Freitas R, Schapira M. A systematic analysis of atomic protein-ligand interactions in the PDB. Medchemcomm. 2017;8(10):1970–1981. doi:10.1039/c7md00381a
   PubMed Web of Science ®Google Scholar
• Gupta S, Dasmahapatra AK. Destabilization potential of phenolics on Abeta fibrils: mechanistic insights from molecular dynamics simulation. Phys Chem Chem Phys. 2020;22(35):19643–19658. doi:10.1039/d0cp02459g
   PubMed Web of Science ®Google Scholar
• Li F, Zhan C, Dong X, et al. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ42 aggregation and disruption of Aβ42 protofibril: similarities and differences. Phys Chem Chem Phys. 2021;23(34):18843–18854. doi:10.1039/d1cp01913a
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Sarkar D, Sasmal S. A Review of green synthesis of metal nanoparticles using algae. Front Microbiol. 2021;12:693899. doi:10.3389/fmicb.2021.693899
   PubMed Web of Science ®Google Scholar
• Barabadi H, Mobaraki K, Jounaki K, et al. Exploring the biological application of Penicillium fimorum-derived silver nanoparticles: in vitro physicochemical, antifungal, biofilm inhibitory, antioxidant, anticoagulant, and thrombolytic performance. Heliyon. 2023;9(6):e16853. doi:10.1016/j.heliyon.2023.e16853
   PubMed Web of Science ®Google Scholar
• Hamida RS, Ali MA, Sharif FT, et al. Biofabrication of silver nanoparticles using Nostoc muscorum Lukesova 2/91: optimization, characterization, and biological applications. Int J Nanomed. 2023;18:5625–5649. doi:10.2147/IJN.S420312
   PubMed Web of Science ®Google Scholar
• Nelis M, Decraecker L, Boeckxstaens G, et al. Development of a HILIC-MS/MS method for the quantification of histamine and its main metabolites in human urine samples. Talanta. 2020;220:121328. doi:10.1016/j.talanta.2020.121328
   PubMed Web of Science ®Google Scholar
• Lv C, Li Q, Liu X, et al. Determination of catecholamines and their metabolites in rat urine by ultra-performance liquid chromatography-tandem mass spectrometry for the study of identifying potential markers for Alzheimer’s disease. J Mass Spectrom. 2015;50(2):354–363. doi:10.1002/jms.3536
   PubMed Web of Science ®Google Scholar
• Liu FF, Dong XY, He L, et al. Molecular insight into conformational transition of amyloid beta-peptide 42 inhibited by (-)-epigallocatechin-3-gallate probed by molecular simulations. J Phys Chem B. 2011;115(41):11879–11887. doi:10.1021/jp202640b
   PubMed Web of Science ®Google Scholar
• Warerkar OD, Mudliar NH, Momin MM, et al. Targeting amyloids with coated nanoparticles: a review on potential combinations of nanoparticles and bio-compatible coatings. Crit Rev Ther Drug Carrier Syst. 2024;41(2):85–119. doi:10.1615/CritRevTherDrugCarrierSyst.2023046209
   PubMed Web of Science ®Google Scholar
• Dourado NS, Souza CDS, de Almeida MMA, et al. Neuroimmunomodulatory and neuroprotective effects of the flavonoid apigenin in in vitro models of neuroinflammation associated with Alzheimer’s disease. Front Aging Neurosci. 2020;12:119. doi:10.3389/fnagi.2020.00119
   PubMed Web of Science ®Google Scholar
• Shimazu R, Anada M, Miyaguchi A, et al. Evaluation of blood-brain barrier permeability of polyphenols, anthocyanins, and their metabolites. J Agric Food Chem. 2021;69(39):11676–11686. doi:10.1021/acs.jafc.1c02898
   PubMed Web of Science ®Google Scholar
• Ono K, Yoshiike Y, Takashima A, et al. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer’s disease. J Neurochem. 2003;87(1):172–181. doi:10.1046/j.1471-4159.2003.01976.x
   PubMed Web of Science ®Google Scholar
• Paul PS, Patel T, Cho JY, et al. Native PLGA nanoparticles attenuate Abeta-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer’s disease pathology. Sci Rep. 2024;14(1):144. doi:10.1038/s41598-023-50465-x
   PubMed Web of Science ®Google Scholar
• Ozdal ZD, Sahmetlioglu E, Narin I, et al. Synthesis of gold and silver nanoparticles using flavonoid quercetin and their effects on lipopolysaccharide induced inflammatory response in microglial cells. 3 Biotech. 2019;9(6):212. doi:10.1007/s13205-019-1739-z
   PubMedGoogle Scholar
• Bras NF, Ashirbaev SS, Zipse H. Combined in silico and in vitro approaches to uncover the oxidation and Schiff base reaction of baicalein as an inhibitor of amyloid protein aggregation. Chemistry. 2022;28(11):e202104240. doi:10.1002/chem.202104240
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao J, Holscher C. Therapeutic potential of baicalein in Alzheimer’s disease and Parkinson’s disease. CNS Drugs. 2017;31(8):639–652. doi:10.1007/s40263-017-0451-y
   PubMed Web of Science ®Google Scholar
• Jalili S, Panji M, Mahdavimehr M, et al. Enhancing anti-amyloidogenic properties and antioxidant effects of Scutellaria baicalensis polyphenols through novel nanoparticle formation. Int J Biol Macromol. 2024;262(Pt 1):130003. doi:10.1016/j.ijbiomac.2024.130003
   PubMedGoogle Scholar
• Simpson CA, Salleng KJ, Cliffel DE, et al. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine. 2013;9(2):257–263. doi:10.1016/j.nano.2012.06.002
   PubMed Web of Science ®Google Scholar
• Kim HS, Lee SJ, Lee DY. Milk protein-shelled gold nanoparticles with gastrointestinally active absorption for aurotherapy to brain tumor. Bioact Mater. 2022;8:35–48. doi:10.1016/j.bioactmat.2021.06.026
   PubMed Web of Science ®Google Scholar
• Geldenhuys W, Mbimba T, Bui T, et al. Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. J Drug Target. 2011;19(9):837–845. doi:10.3109/1061186X.2011.589435
   PubMed Web of Science ®Google Scholar
• Jia H, Hou D, O’Connor D, et al. Exogenous phosphorus treatment facilitates chelation-mediated cadmium detoxification in perennial ryegrass (Lolium perenne L.). J Hazard Mater. 2020;389:121849. doi:10.1016/j.jhazmat.2019.121849
   PubMed Web of Science ®Google Scholar
• Srivastava AK, Pittman JM, Zerweck J, et al. β-Amyloid aggregation and heterogeneous nucleation. Protein Sci. 2019;28(9):1567–1581. doi:10.1002/pro.3674
   PubMed Web of Science ®Google Scholar
• Mirzaei-Behbahani B, Meratan AA, Moosakhani B, et al. Efficient inhibition of amyloid fibrillation and cytotoxicity of alpha-synuclein and human insulin using biosynthesized silver nanoparticles decorated by green tea polyphenols. Sci Rep. 2024;14(1):3907. doi:10.1038/s41598-024-54464-4
   PubMed Web of Science ®Google Scholar
• Gupta DK, Huang HG, Yang XE, et al. The detoxification of lead in Sedum alfredii H. is not related to phytochelatins but the glutathione. J Hazard Mater. 2010;177(1–3):437–444. doi:10.1016/j.jhazmat.2009.12.052
   PubMed Web of Science ®Google Scholar
• Pan Z, Xie R, Chen Z. One-step simultaneous biomass synthesis of iron nanoparticles using tea extracts for the removal of metal(loid)s in acid mine drainage. Chemosphere. 2023;337:139366. doi:10.1016/j.chemosphere.2023.139366
   PubMedGoogle Scholar